KimberlyHigginbothamKoenigMD

PubMed

• Short-Term Biomarker Modulation Study of Dasatinib for Estrogen Receptor-Negative Breast Cancer Chemoprevention.
  Fatma Nihan Akkoc Mustafayev, Diane D Liu, Angelica M Gutierrez, John E Lewis, Nuhad K Ibrahim, Vicente Valero, Daniel J Booser, Jennifer K Litton, Kimberly Koenig, Di...> ;European Journal of Breast Health. 2023 Oct 1
• Targeting chemotherapy resistance in mesenchymal triple-negative breast cancer: a phase II trial of neoadjuvant angiogenic and mTOR inhibition with chemotherapy.
  Nour Abuhadra, Ryan Sun, Roland L Bassett Jr, Lei Huo, Jeffrey T Chang, Mediget Teshome, Alyson R Clayborn, Jason B White, Elizabeth E Ravenberg, Beatriz E Adrada, Ros...> ;Investigational New Drugs. 2023 Jun 1
• 11 citations
  Phase 1 trial of ADI-PEG 20 and liposomal doxorubicin in patients with metastatic solid tumors.
  Shuyang Yao, Filip Janku, Kimberly Koenig, Apostolia Maria Tsimberidou, Sarina Anne Piha-Paul, Nai Shi, John Stewart, Amanda Johnston, John S. Bomalaski, Funda Meric-B...> ;Cancer Medicine. 2021 Nov 28
• 12 citations
  PIK3CA mutations in plasma circulating tumor DNA predict survival and treatment outcomes in patients with advanced cancers.
  Ecaterina Elena Dumbrava, S.G. Call, Haojie Huang, A.L. Stuckett, Kiran Madwani, Abha Adat, David S. Hong, Sarina Anne Piha-Paul, Vivek Subbiah, Daniel D. Karp, Siquin...> ;ESMO Open. 2021 Oct 1
• 4 citations
  Phase I Study of Everolimus, Letrozole, and Trastuzumab in Patients with Hormone Receptor−positive Metastatic Breast Cancer or Other Solid Tumors
  Alexej Ballhausen, Jennifer J. Wheler, Daniel D. Karp, Sarina Anne Piha-Paul, Siqing Fu, Shubham Pant, Apostolia Maria Tsimberidou, David S. Hong, Vivek Subbiah, Veron...> ;Clinical Cancer Research. 2021 Mar 1
• 3 citations
  A Randomized Phase II Study of Sequential Eribulin Versus Paclitaxel Followed by FAC/FEC as Neoadjuvant Therapy in Patients with Operable HER2-Negative Breast Cancer
  Bora Lim, Juhee Song, Nuhad K. Ibrahim, Kimberly B. Koenig, Mariana Chavez-MacGregor, Joe Ensor, Jill Schwartz Gomez, Savitri Krishnamurthy, Abigail S. Caudle, Simona ...> ;The Oncologist. 2021 Feb 1
• 25 citations
  Efficacy and safety of the combination of metformin, everolimus and exemestane in overweight and obese postmenopausal patients with metastatic, hormone receptor-positi...
  Clinton Yam, Francisco J. Esteva, Miral M. Patel, Akshara Singareeka Raghavendra, Naoto T. Ueno, Stacy L. Moulder, Kenneth R. Hess, Girish S. Shroff, Silvia Hodge, Kim...> ;Investigational New Drugs. 2019 Jan 5
• 11 citations
  Rapid breast cancer disease progression following Cyclin Dependent Kinase 4 and 6 inhibitor discontinuation
  Sami I. Bashour, Iman Doostan, Khandan Keyomarsi, Vicente Valero, Naoto T. Ueno, Powel H. Brown, Jennifer K. Litton, Kimberly B. Koenig, Meghan Sri Karuturi, Sausan Ab...> ;Journal of Cancer. 2017 Jul 5
• 130 citations
  Targeting the PI3K/AKT/mTOR Pathway for the Treatment of Mesenchymal Triple-Negative Breast Cancer: Evidence From a Phase 1 Trial of mTOR Inhibition in Combination Wit...
  Reva K. Basho, Michael Z. Gilcrease, Rashmi Krishna Murthy, Thorunn Helgason, Daniel D. Karp, Funda Meric-Bernstam, Kenneth R. Hess, Shelley M. Herbrich, Vicente Valer...> ;JAMA Oncology. 2017 Apr 1
• 13 citations
  Phase I biomarker modulation study of atorvastatin in women at increased risk for breast cancer
  Banu Arun, Yun Gong, Diane Liu, Jennifer K. Litton, Angelica M. Gutierrez-Barrera, J. Jack Lee, Lana Vornik, Nuhad K. Ibrahim, Terri L. Cornelison, Gabriel N. Hortobag...> ;Breast Cancer Research and Treatment. 2016 Jun 10
• 25 citations
  TBCRC-010: Phase I/II Study of Dasatinib in Combination with Zoledronic Acid for the Treatment of Breast Cancer Bone Metastasis
  Zahi Mitri, Rita Nanda, Kimberly L. Blackwell, Colleen M. Costelloe, Ilona Hood, Caimiao Wei, Abenaa M. Brewster, Nuhad K. Ibrahim, Kimberly B. Koenig, Gabriel N. Hort...> ;Clinical Cancer Research. 2016 Dec 1
• 65 citations
  Docetaxel Alone or in Combination With a Therapeutic Cancer Vaccine (PANVAC) in Patients With Metastatic Breast Cancer: A Randomized Clinical Trial
  Christopher R. Heery, Nuhad K. Ibrahim, Philip M. Arlen, Mahsa Mohebtash, James L. Murray, Kimberly Koenig, Ravi A. Madan, Sheri McMahon, Jennifer L. Marte, Seth M. St...> ;JAMA Oncology. 2015 Nov 1
• 17 citations
  Phase II Randomized Study of Ixabepilone Versus Observation in Patients With Significant Residual Disease After Neoadjuvant Systemic Therapy for HER2-Negative Breast C...
  Ana M. Gonzalez-Angulo, Xiudong Lei, Richardo H. Alvarez, Majorie C. Green, James L. Murray, Vicente Valero, Kimberly B. Koenig, Nuhad K. Ibrahim, Jennifer K. Litton, ...> ;Clinical Breast Cancer. 2015 Oct 1
• 49 citations
  Inhibition of the phosphoinositide 3-kinase pathway for the treatment of patients with metastatic metaplastic breast cancer.
  Stacy L. Moulder, Thorunn Helgason, Filip Janku, Jennifer J. Wheler, John W. Moroney, Daniel J. Booser, Constance Albarracin, Phuong Khanh Morrow, Johnique T. Atkins, ...> ;Annals of Oncology. 2015 Jul 1
• 33 citations
  Effect of adjuvant/neoadjuvant trastuzumab on clinical outcomes in patients with HER2-positive metastatic breast cancer
  Rashmi Krishna Murthy, Ankur Varma, Priyankana Mishra, Kenneth R. Hess, Elliana Young, James L. Murray, Kimberly B. Koenig, Stacy Moulder, Amal Melhem-Bertrandt, Sharo...> ;Cancer. 2014 Jul 1
• 185 citations
  Estrogen Receptor (ER) mRNA and ER-Related Gene Expression in Breast Cancers That Are 1% to 10% ER-Positive by Immunohistochemistry
  Takayuki Iwamoto, Daniel J. Booser, Vicente Valero, James L. Murray, Kimberly Koenig, Francisco J. Esteva, Naoto T. Ueno, Jie Zhang, Weiwei Shi, Yuan Qi, Junji Matsuok...> ;Journal of Clinical Oncology. 2012 Mar 1
• Breslow thickness and clark level in melanoma: support for including level in pathology reports and in American Joint Committee on Cancer Staging.
  Marghoob AA, Koenig K, Bittencourt FV, Kopf AW, Bart RS> ;Cancer. 2000-02-01
• Join now to see all